跳至主要内容
临床试验/TCTR20210416003
TCTR20210416003已完成3 期

The Effectiveness of Perioperative Parecoxib Intravenous Administration in the Surgical Fixation of Unstable Ankle Fracture: A Prospective, Double-Blinded, Randomized, Placebo-Controlled Trial.

American Orthopaedic Foot & Ankle Society0 个研究点目标入组 40 人开始时间: 2021年4月16日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

Perioperative administration of parecoxib could not significantly provide better postoperative pain control and lower amount of opioid requirement than placebo. Single benefit of perioperative use of parecoxib seemed to be shorter length of hospital stay than placebo.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • The patient with unstable ankle fracture who had the indication for open reduction and internal fixation.

排除标准

  • The contraindication of parecoxib use (1 pateint), thrombocytopenia on preoperative blood work (1 patient), head injury with contraindication for spinal anesthesia (1 patient), and acute on chronic fracture (1 patient).

研究者

发起方
American Orthopaedic Foot & Ankle Society

相似试验

The Effectiveness of Perioperative Parecoxib... | 临床试验